WALTERS GROUP

ZNTL

WALTERS GROUP serves as 10 percent owner at Zentalis Pharmaceuticals, Inc. (ZNTL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$22.92M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$22.92M

Companies Traded

ZNTL

Active Period

Dec 2025 – Aug 2026

2 total trades

Most Recent

Buy ZNTL

Aug 19, 2026 · $15.17M

WALTERS GROUP's Insider Trading at Zentalis Pharmaceuticals, Inc. (ZNTL)

Buys

2 · $22.92M

Sells

0 · $0.00

Total Shares Bought

10,794,973

Total Shares Sold

ZNTL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 19, 2026	Buy	4,335,000	$3.50	$15.17M	17,844,972
Dec 31, 2025	Buy	6,459,973	$1.20	$7.75M	0

Related Insiders

Ingmar Bruns

officer: Chief Medical Officer

ZNTLSell · Feb 10, 2026

EASTLAND JULIA MARIE

director, officer: CEO & President

ZNTLSell · Feb 10, 2026

Vultaggio Vincent

PAO and PFO

ZNTLSell · Feb 10, 2026

Explore More Insider Trading Data

ZNTL Insider Trading Activity

View all insider trades at Zentalis Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity